2ND LOOK SURGERY FOR RECURRENT COLORECTAL-CARCINOMA - IS IT WORTHWHILE

被引:7
作者
BLEDAY, R [1 ]
STEELE, G [1 ]
机构
[1] NEW ENGLAND DEACONESS HOSP,CANC BIOL LAB,110 FRANCIS ST,SUITE 3-A,BOSTON,MA 02215
来源
SEMINARS IN SURGICAL ONCOLOGY | 1991年 / 7卷 / 03期
关键词
SYSTEMIC THERAPY; DEBULKING PROCEDURE; LIVER; PULMONARY; REGIONAL RECURRENCES;
D O I
10.1002/ssu.2980070311
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Second-look surgery for recurrent colorectal carcinoma has been advocated for over four decades. Routine follow-up procedures gave way to clinically directed or carcinoembryonic (CEA)-directed procedures in the mid-1970's. In this paper, we review the results of second-look surgery for recurrent colorectal carcinoma and ask the question, "Is it worthwhile?" Excluding surgery for symptomatic patients, we conclude that second-look surgery should only be performed for recurrent colorectal carcinoma with the intent of rendering the patient disease-free. Without effective systemic therapy, "palliative" or "debulking" procedures probably do not increase survival. The most likely candidates for such a curative approach with second-look surgery are those with isolated liver, pulmonary, and, less frequently, regional recurrences.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 50 条
[21]  
Cochrane JPS, Williams JT, Faber RG, Et al., Value of outpatient follow‐up after curative surgery for carcinoma of the large bowel, Br Med J, 280, pp. 593-595, (1980)
[22]  
Steele G, Zamcheck N, Wilson RE, Et al., Results of CEA initiated second look surgery, Am J Surg, 139, pp. 544-548, (1980)
[23]  
Fucini C, Tommasi SM, Rosi S, Et al., Follow up of colorectal cancer resected for cure: An experience with CEA, TPA, Ca 19‐9 analysis and second‐look surgery, Dis Colon Rectum, 30, pp. 273-277, (1987)
[24]  
Vassilopoulos PP, Yoon JM, Ledesma EJ, Mittelman A, Treatment of recurrence of adenocarcinoma of the colon and rectum at the anastomotic site, Surg Gynecol Obstet, 152, pp. 777-780, (1982)
[25]  
Kemeny N, Daly J, Reichman B, Et al., Intrahepatic or systemic infusion of flourodeoxy uridine in patients with liver metastases from colorectal carcinoma, Ann Intern Med, 107, pp. 459-465, (1987)
[26]  
Adjuvant therapy for colon cancer: Results of a prospective randomized trial, N Engl J Med, 310, pp. 737-743, (1984)
[27]  
A controlled trial of adjuvant chemotherapy, radiation therapy, or combined chemoradiation therapy following curative resection for rectal carcinoma, N Engl J Med, 312, pp. 1465-1472, (1985)
[28]  
Steele GD, Ravikumar TS, Resection of hepatic metastases from colorectal cancer: Biologic perspectives, Ann Surg, 210, pp. 127-138, (1989)
[29]  
Wagner JS, Adson MA, Van Heerden JA, Et al., The natural history of hepatic metastases from colorectal cancer, Ann Surg, 199, pp. 502-507, (1984)
[30]  
Fortner JG, Recurrence of colorectal cancer after hepatic resection, Am J Surg, 155, pp. 378-382, (1988)